Telomere length and outcomes in ischaemic heart failure: data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA).
- Citation data:
European journal of heart failure, ISSN: 1879-0844, Vol: 17, Issue: 3, Page: 313-9
- Publication Year:
- Medicine; leucocyte telomere length; ageing; heart failure; healthy ageing; Cardiology
Leucocyte telomere length is considered a marker of biological ageing and has been suggested to be shorter in patients with CAD and heart failure compared with healthy controls. The aim of this study was to determine whether telomere length is associated with clinical outcomes in patients with ischaemic heart failure and whether this association is superior to chronological age as defined by date of birth.